OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synthesis, docking study, and in vitro anticancer evaluation of new flufenamic acid derivatives
Ammar I. Al-Bayati, Ammar A. Razzak Mahmood, Zainab A. Al-Mazaydeh, et al.
Pharmacia (2021) Vol. 68, Iss. 2, pp. 449-461
Open Access | Times Cited: 11
Ammar I. Al-Bayati, Ammar A. Razzak Mahmood, Zainab A. Al-Mazaydeh, et al.
Pharmacia (2021) Vol. 68, Iss. 2, pp. 449-461
Open Access | Times Cited: 11
Showing 11 citing articles:
Synthesis, docking study, and structure activity relationship of novel anti-tumor 1, 2, 4 triazole derivatives incorporating 2-(2, 3- dimethyl aminobenzoic acid) moiety
Hiba Najeh Al-Saad, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni, et al.
Pharmacia (2022) Vol. 69, Iss. 2, pp. 415-428
Open Access | Times Cited: 20
Hiba Najeh Al-Saad, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni, et al.
Pharmacia (2022) Vol. 69, Iss. 2, pp. 415-428
Open Access | Times Cited: 20
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship
Omeed M. Hassan, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1336-1348
Closed Access | Times Cited: 10
Omeed M. Hassan, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1336-1348
Closed Access | Times Cited: 10
Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities
Yahya Saad Yaseen, Ammar A. Razzak Mahmood Kubba, Wurood A. Shihab, et al.
Pharmacia (2022) Vol. 69, Iss. 3, pp. 595-614
Open Access | Times Cited: 15
Yahya Saad Yaseen, Ammar A. Razzak Mahmood Kubba, Wurood A. Shihab, et al.
Pharmacia (2022) Vol. 69, Iss. 3, pp. 595-614
Open Access | Times Cited: 15
Design, Synthesis, and Molecular Docking Studies of 5‐Bromoindole‐2‐Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR‐2 Inhibitory Effects
Omeed M. Hassan, Ammar A. Razzak Mahmood, Ali H. Hamzah, et al.
ChemistrySelect (2022) Vol. 7, Iss. 46
Open Access | Times Cited: 13
Omeed M. Hassan, Ammar A. Razzak Mahmood, Ali H. Hamzah, et al.
ChemistrySelect (2022) Vol. 7, Iss. 46
Open Access | Times Cited: 13
New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment
Abbas A. Ridha Mehihi, Ammar A. Razzak Mahmood Kubba, Wurood A. Shihab, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 11, pp. 2334-2348
Closed Access | Times Cited: 7
Abbas A. Ridha Mehihi, Ammar A. Razzak Mahmood Kubba, Wurood A. Shihab, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 11, pp. 2334-2348
Closed Access | Times Cited: 7
Organometallic gold (III) and platinum (II) complexes with thiosemicarbazone: Structural behavior, anticancer activity, and molecular docking
Carolane M. Almeida, Pedro H. S. Marcon, Érica C. M. Nascimento, et al.
Applied Organometallic Chemistry (2022) Vol. 36, Iss. 8
Closed Access | Times Cited: 12
Carolane M. Almeida, Pedro H. S. Marcon, Érica C. M. Nascimento, et al.
Applied Organometallic Chemistry (2022) Vol. 36, Iss. 8
Closed Access | Times Cited: 12
New Indole‐6‐Carboxylic Acid Derivatives as Multi‐Target Antiproliferative Agents: Synthesis, in Silico Studies, and Cytotoxicity Evaluation
Mustafa M. Allawi, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, et al.
Chemistry & Biodiversity (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 5
Mustafa M. Allawi, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, et al.
Chemistry & Biodiversity (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 5
Anti-proliferation evaluation of new derivatives of indole-6-carboxylate ester as receptor tyrosine kinase inhibitors
Mustafa M. Allawi, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 13, pp. 1313-1331
Closed Access | Times Cited: 1
Mustafa M. Allawi, Ammar A. Razzak Mahmood, Lubna H. Tahtamouni, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 13, pp. 1313-1331
Closed Access | Times Cited: 1
New 4-amino-3-chloro benzoate ester derivatives as EGFR inhibitors: synthesis, in silico and biological analyses
Nedaa A. Abd Al Rahim, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2647-2662
Closed Access
Nedaa A. Abd Al Rahim, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2647-2662
Closed Access
Discovery of new fenamate-based derivatives as anticancer agents and potent VEGFR-2 inhibitors
Abbas A. Ridha Mehihi, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni
International Journal of Health Sciences (2022), pp. 9160-9179
Open Access | Times Cited: 2
Abbas A. Ridha Mehihi, Ammar A. Razzak Mahmood Kubba, Lubna H. Tahtamouni
International Journal of Health Sciences (2022), pp. 9160-9179
Open Access | Times Cited: 2
Synthesis, Molecular Docking Studies, and In vitro Anticancer Evaluation of Novel Tolfenamic Acid Derivatives
Lubna H. Tahtamouni, Abbas A. Mehihi, Ammar A. Razzak Mahmood Kubba
Letters in Drug Design & Discovery (2022) Vol. 20, Iss. 9, pp. 1393-1413
Closed Access | Times Cited: 1
Lubna H. Tahtamouni, Abbas A. Mehihi, Ammar A. Razzak Mahmood Kubba
Letters in Drug Design & Discovery (2022) Vol. 20, Iss. 9, pp. 1393-1413
Closed Access | Times Cited: 1
